Randall A Lipps bought $350K of Omnicell (OMCL)

Executed Mar 14 2025, disclosed Mar 18 2025, 4 days later.

Value, as filed

$350K

10,561 sh × $33.13

Executed

Mar 14 2025

the trade date, as filed

Disclosed

Mar 18 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

-5.4%

-4.1% from execution

Over the 21 trading sessions from the disclosed entry session (Mar 18 2025), the stock returned -5.4% (delay-adjusted); from the execution session (Mar 14 2025), -4.1%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

Randall A Lipps CHAIRMAN, PRESIDENT AND CEO profile →

Randall A Lipps (CHAIRMAN, PRESIDENT AND CEO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Omnicell, Inc. (OMCL). The largest single filing was $1.0M of OMCL (28,250 sh × $35.97, as filed), executed Dec 1 2025.

The name

OMCL

Omnicell, Inc. OMCL · Healthcare · 13 filings in 24 months ticker →

Healthcare · Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Randall A Lipps in OMCL

OMCLSALE Omnicell, Inc. $470K
10,000 sh × $47.00
Exec Jul 15
Filed Jul 17 · 4:05 PM ET OMCLSALE Omnicell, Inc. $1.0M
28,250 sh × $35.97
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET